New research presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD), Hamburg (2–6 Oct), shows that treatment with the drug semaglutide significantly improves blood sugar control and weight loss in adults with type 2 diabetes for up to three years…
Read More
About The Author
